Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats

Nutrients

Volumn 6, Issue 6, 2014, Pages 2179-2195

  Song, Yuno ^a   Lee, Soo Jung ^a   Jang, Sun Hee ^a   Ha, Ji Hee ^a   Song, Young Min ^a   Ko, Yeoung Gyu ^b   Kim, Hong Duck ^c   Min, Wongi ^a   Kang, Suk Nam ^d   Cho, Jae Hyeon ^a  

^a Gyeongsang National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d Daegu University   (South Korea)

Author keywords

Hepatic gene expression; Hepatic steatosis; High fat diet; Sasa borealis stem

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID SYNTHASE; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; SASA BOREALIS EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; ANTIOXIDANT; CHOLESTEROL; FAT INTAKE; PHENOL DERIVATIVE; TRIACYLGLYCEROL;

ABTS RADICAL SCAVENGING ASSAY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ASSAY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; EVAPORATION; EXPERIMENTAL OBESITY; FATTY LIVER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYDROXYL RADICAL SCAVENGING ASSAY; LIPID DIET; LIPID LIVER LEVEL; LIPID OXIDATION; LIPID STORAGE; LIPOGENESIS; LIVER PROTECTION; LIVER WEIGHT; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PLANT STEM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SASA; SASA BOREALIS; SERIAL ANALYSIS OF GENE EXPRESSION; SPECTROPHOTOMETER; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; FAT INTAKE; LIVER; OBESITY; ORGAN SIZE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; CHOLESTEROL; DIETARY FATS; FATTY LIVER; FLAVONOIDS; LIVER; MALE; OBESITY; ORGAN SIZE; PHENOLS; PLANT EXTRACTS; PLANT STEMS; RATS; RATS, SPRAGUE-DAWLEY; SASA; TRIGLYCERIDES;

EID: 84902094667     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6062179     Document Type: Article

References (37)

1. Ludwig, J.; Viggiano, T.R.; McGill, D.B.; Oh, B.J. Nonalcoholic steatohepatitis: Mayo clinic experience with a hitherto unnamed disease. Mayo Clin. Proc. 1980, 55, 434-438.
2. Marchesini, G.; Bugianesi, E.; Forlani, G.; Cerrelli, F.; Lenzi, M.; Manini, R.; Natale, S.; Vanni, E.; Villanova, N.; Melchionda, N.; Rizzetto, M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37, 917-923.
3. Powell, E.E.; Cooksley, W.G.; Hanson, R.; Searle, J.; Halliday, J.W.; Powell, L.W. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11, 74-80.
4. Marchesini, G.; Brizi, M.; Bianchi, G.; Tomassetti, S.; Bugianesi, E.; Lenzi, M.; McCullough, A.J.; Natale, S.; Forlani, G.; Melchionda, N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001, 50, 1844-1850.
5. Fon Tacer, K.; Rozman, D. Nonalcoholic fatty liver disease: Focus on lipoprotein and lipid deregulation. J. Lipids 2011, 2011, 783976.
6. Browning, J.D.; Horton, J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Investig. 2004, 114, 147-152.
7. Nagle, C.A.; Klett, E.L.; Coleman, R.A. Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 2009, 50, S74-S79.
8. Prior, R.L.; Cao, G. Antioxidant capacity and polyphenolic components of teas: Implications for altering in vivo antioxidant status. Proc. Soc. Exp. Biol. Med. 1999, 220, 255-261.
9. Lu, B.; Wu, X.; Tie, X.; Zhang, Y.; Zhang, Y. Toxicology and safety of anti-oxidant of bamboo leaves. Part 1: Acute and subchronic toxicity studies on anti-oxidant of bamboo leaves. Food Chem. Toxicol. 2005, 43, 783-792.
10. Lu, B.; Wu, X.; Shi, J.; Dong, Y.; Zhang, Y. Toxicology and safety of antioxidant of bamboo leaves. Part 2: Developmental toxicity test in rats with antioxidant of bamboo leaves. Food Chem. Toxicol. 2006, 44, 1739-1743.
11. Choi, Y.J.; Lim, H.S.; Choi, J.S.; Shin, S.Y.; Bae, J.Y.; Kang, S.W.; Kang, I.J.; Kang, Y.H. Blockade of chronic high glucose-induced endothelial apoptosis by Sasa borealis bamboo extract. Exp. Biol. Med. (Maywood) 2008, 233, 580-591.
12. Lee, M.J.; Park, W.H.; Song, Y.S.; Lee, Y.W.; Song, Y.O.; Moon, G.S. Effect of bamboo culm extract on oxidative stress and genetic expression: Bamboo culm extract ameliorates cell adhesion molecule expression and NFkappaB activity through the suppression of the oxidative stress. Clin. Nutr. 2008, 27, 755-763.
13. Park, E.J.; Jhon, D.Y. Effects of bamboo shoot consumption on lipid profiles and bowel function in healthy young women. Nutrition 2009, 25, 723-728.
14. Zhang, Y.; Yao, X.; Bao, B.; Zhang, Y. Anti-fatigue activity of a triterpenoid-rich extract from Chinese bamboo shavings (Caulis bamfusae in taeniam). Phytother. Res. 2006, 20, 872-876.
15. Ko, B.S.; Jun, D.W.; Jang, J.S.; Kim, J.H.; Park, S. Effect of Sasa borealis and white lotus root and leaves on insulin action and secretion in vitro. Korea J. Food Sci. Technol. 2006, 38, 114-120.
16. Kim, E.Y.; Jung, E.Y.; Lim, H.S.; Heo, Y.R. The effects of the Sasa borealis leaves extract on plasma adiponectin, restin, C-reactive protein and homocyteine levels in high fat diet-induced obese C57/BL6J mice. Korean J. Nutr. 2007, 40, 303-311.
17. Park, H.S.; Lim, J.H.; Kim, H.J.; Choi, H.J.; Lee, I.S. Antioxidant flavone glycosides from the leaves of Sasa borealis. Arch. Pharm. Res. 2007, 30, 161-166.
18. Shibata, M.; Yamatake, M.; Sakamoto, M.; Kanamori, K.; Takagi, K.; Okabe, S. Pharmacological studies on bamboo grass. Nippon Yakurigaku Zassi 1975, 71, 481-485.
19. Singleton, V.L.; Rossi, J.R. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid. Am. J. Enol. Vitic. 1965, 16, 144-158.
20. Meda, A.; Lamien, C.E.; Romito, M.; Millogo, J.; Nacoulma, O.G. Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activity. Food Chem. 2005, 91, 571-577.
21. Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci. 1995, 28, 25-30.
22. Halliwell, B.; Gutteridge, J.M.C.; Arurma, O.I. The deoxyribose method: A simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem. 1987, 165, 215-219.
23. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231-1237.
24. Beaton, M.D. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Can. J Gastroenterol. 2012, 26, 353-357.
25. Hirako, S.; Kim, H.J.; Shimizu, S.; Chiba, H.; Matsumoto, A. Low-dose fish oil consumption prevents hepatic lipid accumulation in high cholesterol diet fed mice. J Agric. Food Chem. 2011, 59, 13353-13359.
26. Bradbury, M.W. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G194-G198.
27. Cho, A.S.; Jeon, S.M.; Kim, M.J.; Yeo, J. Seo, K.I.; Choi, M.S.; Lee, M.K. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem. Toxicol. 2010, 48, 937-943.
28. Kwon, H.J.; Kim, Y.Y.; Choung, S.Y. Amelioration effects of traditional Chinese medicine on alcohol-induced fatty liver. World J. Gastroenterol. 2005, 11, 5512-5516.
29. Sekiya, M.; Yahagi, N.; Matsuzaka, T.; Najima, Y.; Nakakuki, M.; Nagai, R.; Ishibashi, S.; Osuga, J.; Yamada, N.; Shimano, H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38, 1529-1539.
30. Shimano, H.; Horton, J.D.; Shimomura, I.; Hammer, R.E.; Brown, M.S.; Goldstein, J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Investig. 1997, 99, 846-854.
31. Yang, Z.X.; Shen, W.; Sun, H. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol. Int. 2010, 4, 741-748.
32. Takahashi, N.; Senda, M.; Lin, S.; Goto, T.; Yano, M.; Sasaki, T.; Murakami, S.; Kawada, T. Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice. Mol. Nutr. Food Res. 2011, 55, 1791-1797.
33. Nagasawa, T.; Inada, Y.; Nakano, S.; Tamura, T.; Takahashi, T.; Maruyama, K.; Yamazaki, Y.; Kuroda, J.; Shibata, N. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine-and choline-deficient diet. Eur. J. Pharmacol. 2006, 536, 182-191.
34. Stone, S.J.; Myers, H.M.; Watkins, S.M.; Brown, B.E.; Feingold, K.R.; Elias, P.M.; Farese, R.V., Jr. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 2004, 279, 11767-11776.
35. Yamazaki, T.; Sasaki, E.; Kakinuma, C.; Yano, T.; Miura, S.; Ezaki, O. Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT. J. Biol. Chem. 2005, 280, 21506-21514.
36. Sookoian, S.; Rosselli, M.S.; Gemma, C.; Burgueño, A.L.; Fernández Gianotti, T.; Castaño, G.O.; Pirola, C.J. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology 2010, 52, 1992-2000.
37. Fujiki, K.; Kano, F.; Shiota, K.; Murata, M. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol. 2009, 7, 38, doi:10.1186/1741-7007-7-38.